HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amynah A Pradhan Selected Research

Nitroglycerin (Dynamite)

1/2022Migraine and peripheral pain models show differential alterations in neuronal complexity.
1/2021Delta opioid receptor regulation of calcitonin gene-related peptide dynamics in the trigeminal complex.
1/2021Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition.
1/2021A non-convulsant delta-opioid receptor agonist, KNT-127, reduces cortical spreading depression and nitroglycerin-induced allodynia.
10/2020Forebrain delta opioid receptors regulate the response of delta agonist in models of migraine and opioid-induced hyperalgesia.
1/2020NOP receptor agonist attenuates nitroglycerin-induced migraine-like symptoms in mice.
1/2020Acid-sensing ion channel 3 blockade inhibits durovascular and nitric oxide-mediated trigeminal pain.
1/2019Delta opioid receptor agonists are effective for multiple types of headache disorders.
1/2018Soluble guanylyl cyclase is a critical regulator of migraine-associated pain.
1/2018Gene Network Dysregulation in the Trigeminal Ganglia and Nucleus Accumbens of a Model of Chronic Migraine-Associated Hyperalgesia.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Amynah A Pradhan Research Topics

Disease

19Migraine Disorders (Migraine)
01/2022 - 02/2014
15Pain (Aches)
01/2022 - 10/2011
15Hyperalgesia
10/2021 - 02/2014
6Chronic Pain
01/2018 - 10/2011
4Headache (Headaches)
01/2021 - 01/2017
3Headache Disorders (Headache Syndromes)
10/2020 - 01/2019
2Secondary Headache Disorders
10/2020 - 01/2019
2Hypersensitivity (Allergy)
10/2016 - 05/2014
1Epilepsy (Aura)
10/2020
1Photophobia (Light Sensitivity)
01/2020
1Post-Traumatic Headache
01/2019
1Mood Disorders (Mood Disorder)
01/2018
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2017
1Acute Pain
05/2014
1Infections
07/2013
1Vesicular Stomatitis
07/2013
1Neuroblastoma
07/2013
1Substance-Related Disorders (Drug Abuse)
10/2011
1Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
10/2011
1Brain Diseases (Brain Disorder)
10/2011

Drug/Important Bio-Agent (IBA)

15Nitroglycerin (Dynamite)FDA LinkGeneric
01/2022 - 02/2014
10delta Opioid Receptors (delta Opioid Receptor)IBA
01/2021 - 10/2011
9Opioid Analgesics (Opioids)IBA
10/2021 - 10/2011
64- (alpha- (4- allyl- 2,5- dimethyl- 1- piperazinyl)- 3- methoxybenzyl)- N,N- diethylbenzamideIBA
01/2021 - 05/2014
5Opioid Receptors (Opioid Receptor)IBA
01/2017 - 11/2012
4Sumatriptan (Imigran)FDA LinkGeneric
01/2019 - 02/2014
3Morphine (MS Contin)FDA LinkGeneric
10/2021 - 01/2017
3Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2020 - 02/2014
3NeuropeptidesIBA
12/2019 - 03/2015
2Protein Isoforms (Isoforms)IBA
10/2021 - 01/2018
2Calcitonin Gene-Related PeptideIBA
01/2021 - 12/2019
2Tryptamines (Triptans)IBA
01/2020 - 01/2019
2Topiramate (Topamax)FDA LinkGeneric
01/2018 - 02/2014
2Propranolol (Inderal)FDA LinkGeneric
01/2018 - 10/2016
1KNT 127IBA
01/2021
1ConvulsantsIBA
01/2021
1Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA
01/2021
1kappa Opioid Receptors (kappa Opioid Receptor)IBA
10/2020
1Acid Sensing Ion ChannelsIBA
01/2020
1Ro 64-6198IBA
01/2020
1cis- 1- methyl- 7- ((4- (2,6- dichlorophenyl)piperidin- 1- yl)methyl)- 6,7,8,9- tetrahydro- 5H- benzocyclohepten- 5- olIBA
01/2020
1Therapeutic UsesIBA
01/2020
1ChromograninsIBA
12/2019
1Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
12/2019
1Peptides (Polypeptides)IBA
12/2019
1Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
12/2019
1VorinostatFDA Link
01/2019
1Histone Deacetylase InhibitorsIBA
01/2019
1Ethanol (Ethyl Alcohol)IBA
01/2019
1Pharmaceutical PreparationsIBA
01/2018
1Nitric Oxide Synthase (NO Synthase)IBA
01/2018
1Peroxynitrous Acid (Peroxynitrite)IBA
01/2018
1Soluble Guanylyl CyclaseIBA
01/2018
1RNA (Ribonucleic Acid)IBA
01/2018
1Memantine (Namenda)FDA Link
10/2016
1Valproic Acid (Depakote)FDA LinkGeneric
10/2016
1Amiloride (Midamor)FDA LinkGeneric
10/2016
1beta-Arrestin 1IBA
03/2016
1Substance PIBA
03/2015
1Analgesics (Analgesic Drugs)IBA
03/2015
19- (8- azabicyclo(3.2.1)oct- 3- ylidene)- 9H- xanthene- 3- carboxylic acid diethylamideIBA
05/2014
1Anti-Anxiety Agents (Anxiolytics)IBA
05/2014
1Antidepressive Agents (Antidepressants)IBA
05/2014
1Phosphodiesterase 5 InhibitorsIBA
02/2014
1Sildenafil Citrate (Viagra)FDA Link
02/2014
1Cre recombinaseIBA
07/2013
1Green Fluorescent ProteinsIBA
07/2013
1GTP-Binding Proteins (G-Protein)IBA
07/2013

Therapy/Procedure

9Therapeutics
01/2021 - 02/2014
2Drug Therapy (Chemotherapy)
01/2022 - 01/2021
2Pain Management
10/2020 - 01/2017